In striking contrast, co-expression of SKP2 and myr-AKT1 led to the development of multiple HCC and HCA 18 weeks post injection in all doubly-injected mice (Fig. 5B; Supplementary Table 2). Here, SKP2 is linked to hepatocellular carcinoma.